• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

International experts call for action for world's 450 million scabies sufferers

Bioengineer by Bioengineer
June 14, 2019
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The public health control of scabies: priorities for research and action

IMAGE

Credit: Dr Millicent Osti, MCRI

An alignment of researchers, health ministries and the World Health Organization has outlined the key steps to develop a global program to control scabies – the parasitic disease that affects 450 million people each year in mainly low-income countries.

The research paper, ‘The public health control of scabies: priorities for research and action’ published in The Lancet journal was led by Australia’s Murdoch Children’s Research Institute, in collaboration with the International Alliance for the Control of Scabies, the World Health Organization, international researchers and the Ministries of Health of Ethiopia, Solomon Islands and Fiji.

Lead author, MCRI’s Daniel Engelman, said global scabies control was dependent on developing key operational procedures, including methods for identifying scabies prevalence in all impacted countries.

“Scabies is a disease of poverty, and people in low-income, crowded, and warm environments are most vulnerable to infestation caused by the microscopic Sarcoptes scabiei mite,” Dr Engelman said.

“Scabies causes skin rash and severe itch that can be unbearable, but there is no blood-test, and not even a standardised approach to diagnosis. We don’t know how prevalent scabies is in most countries. ”

Dr Engelman said that a major priority was mapping the global scabies problem using simple skin examinations, which can be conducted by nurses and community health workers.

Dr Mike Kama, public health expert and scabies focal person at the Fiji Ministry of Health, said scabies infection rates could now be radically decreased by treating whole populations with an antiparasitic medication called ivermectin, after previous successful trials of the drug in Fiji.

“Scientific advances over the past five years suggest that the number of people with scabies in a community can be reduced by more than 90 per cent with a single mass treatment” he said. “This is one of the most effective public health interventions we have.”

Dr Paul Cantey, Medical Officer for Scabies from the World Health Organization in Geneva, said more work is required to identify when mass treatments for scabies are needed, how best to implement them, and how to engage communities to ensure scabies control initiatives are sustainable.

“During studies of mass treatment for scabies, young children were not given ivermectin but treated with topical medicines, which can make treatment of affected communities more complicated. This paper highlights the need to determine if oral scabies medicines can be safely given to young children,” Dr Cantey said.

The research found scabies infection rates were high in many Pacific nations, parts of South America and Africa, and in Australian, New Zealand and Canadian indigenous communities, where up to 50 per cent of children may have scabies.

Senior author, MCRI’s Professor Andrew Steer, said the scabies mite causes ‘traumatic itching’ when the surface of the skin is broken, allowing bacteria to enter.

“This can lead to impetigo (school sores), and if the wound becomes infected with the Strep A or Staph bacteria, the sufferer can develop severe, life-threatening infections, as well as chronic health issues such as rheumatic heart disease or chronic kidney disease,” Prof Steer said.

More than 300,000 people die from rheumatic heart disease around the world every year. Prof Steer said that there was the potential to reduce the burden of rheumatic heart disease by controlling scabies and maintaining healthy skin.

The 24 authors of the paper called for a global strategy to tackle scabies and outlined five key steps:

  • Develop a global strategy for the public health control of scabies
  • Map the global population affected by scabies.
  • Facilitate affordable and reliable access to effective treatments
  • Scale-up mass drug administration strategies in highly-affected countries.
  • Work together with affected communities and health programs

###

Available for interview:

Dr Daniel Engelman

Media Contacts:

Christine Tondorf

MCRI communications advisor

+613 9936 6197 / +61413 307 092

[email protected]

Bridie Byrne

MCRI communications specialist

+613 9936 6211 / +61 403 664 416

[email protected]

Media Contact
Christine Tondorf
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/S0140-6736(19)31136-5

Tags: Disease in the Developing WorldHealth CareInfectious/Emerging DiseasesMedicine/HealthPublic HealthUndergraduate
Share19Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary AI Technology Paves the Way for Innovative Materials to Replace Lithium-Ion Batteries

Rising Use of Cannabis for Chronic Health Issues Amid Ongoing Uncertainty

Moffitt Cancer Center Initiates Study to Enhance Advanced Lung Cancer Outcomes in Black Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.